Genetic testing confirmed an uncommon <i>BCR::PDGFRA</i> and coexisting <i>PDGFRA</i> mutations (c.1666G>A and c.1701A>G), confirming the diagnosis of myeloid neoplasm with <i>BCR::PDGFRA</i> rearrangement. Here, BCR is linked to myeloid neoplasm.